[
    [
        {
            "time": "",
            "original_text": "华兰生物半年报点评：业绩符合预期，四价流感疫苗可期",
            "features": {
                "keywords": [
                    "华兰生物",
                    "半年报",
                    "业绩",
                    "符合预期",
                    "四价流感疫苗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华兰生物半年报点评：业绩符合预期，四价流感疫苗可期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]